| 11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study |
juliekok |
May 2, 2010 6:32:51 PM |
| Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles |
juliekok |
Apr 30, 2010 8:13:27 PM |
| Alzheimer disease in the US population: prevalence estimates using the 2000 census |
ked4p |
Mar 2, 2010 12:14:32 AM |
| Detoxification of a bacterial toxin by the toxin itself |
law2yd |
Mar 1, 2010 4:13:08 AM |
| Antibody-Mediated Resolution of Light Chain-Associated Amyloid Deposits |
law2yd |
Mar 1, 2010 3:47:39 AM |
| Antibody-Mediated Resolution of Light Chain-Associated Amyloid Deposits |
law2yd |
Mar 1, 2010 3:47:37 AM |
| Antibody-Mediated Resolution of Light Chain-Associated Amyloid Deposits |
law2yd |
Mar 1, 2010 3:46:34 AM |
| Antibody-Mediated Resolution of Light Chain-Associated Amyloid Deposits |
law2yd |
Mar 1, 2010 3:37:02 AM |
| Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers |
law2yd |
Mar 1, 2010 3:29:26 AM |
| Antibody-mediated resolution of light chain-associated amyloid deposits |
law2yd |
Mar 1, 2010 3:17:53 AM |
